Return on Equity (ROE)
since 2005
Calculation
Abiomed Inc., ROE, long-term trends, calculation
| ROE | = | 100 | × | Net income (loss)1 | ÷ | Stockholders’ equity1 | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | 9.08% | = | 100 | × | 136,505) | ÷ | 1,503,326) |
| Mar 31, 2021 | 16.96% | = | 100 | × | 225,525) | ÷ | 1,329,675) |
| Mar 31, 2020 | 19.05% | = | 100 | × | 203,009) | ÷ | 1,065,466) |
| Mar 31, 2019 | 27.65% | = | 100 | × | 259,016) | ÷ | 936,890) |
| Mar 31, 2018 | 16.27% | = | 100 | × | 112,170) | ÷ | 689,524) |
| Mar 31, 2017 | 11.53% | = | 100 | × | 52,116) | ÷ | 452,071) |
| Mar 31, 2016 | 10.34% | = | 100 | × | 38,147) | ÷ | 368,775) |
| Mar 31, 2015 | 38.99% | = | 100 | × | 113,688) | ÷ | 291,560) |
| Mar 31, 2014 | 4.37% | = | 100 | × | 7,351) | ÷ | 168,353) |
| Mar 31, 2013 | 10.95% | = | 100 | × | 15,014) | ÷ | 137,080) |
| Mar 31, 2012 | 1.18% | = | 100 | × | 1,495) | ÷ | 126,297) |
| Mar 31, 2011 | -11.22% | = | 100 | × | (11,755) | ÷ | 104,743) |
| Mar 31, 2010 | -17.62% | = | 100 | × | (19,024) | ÷ | 107,956) |
| Mar 31, 2009 | -27.24% | = | 100 | × | (31,597) | ÷ | 115,983) |
| Mar 31, 2008 | -43.73% | = | 100 | × | (40,930) | ÷ | 93,594) |
| Mar 31, 2007 | -22.84% | = | 100 | × | (27,881) | ÷ | 122,095) |
| Mar 31, 2006 | -42.38% | = | 100 | × | (29,449) | ÷ | 69,488) |
| Mar 31, 2005 | -4.17% | = | 100 | × | (2,342) | ÷ | 56,179) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
Comparison to Competitors
Abiomed Inc., ROE, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | Cigna Group | CVS Health Corp. | Danaher Corp. | Elevance Health Inc. | Humana Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | 9.08% | 18.90% | 14.86% | 5.84% | 14.39% | 16.59% | 18.33% | 11.98% | 9.59% | 25.87% |
| Mar 31, 2021 | 16.96% | 19.75% | 11.39% | 10.54% | 14.24% | 16.93% | 18.24% | 14.32% | 7.01% | 24.09% |
| Mar 31, 2020 | 19.05% | 13.71% | 16.81% | 10.35% | 9.17% | 13.77% | 24.53% | 10.90% | 9.44% | 23.52% |
| Mar 31, 2019 | 27.65% | 11.86% | 11.26% | 10.39% | 9.94% | 15.15% | 22.49% | 16.69% | 9.25% | 24.02% |
| Mar 31, 2018 | 16.27% | 7.76% | 6.43% | -1.02% | 9.40% | 13.14% | 16.56% | 16.89% | 6.12% | 23.19% |
| Mar 31, 2017 | 11.53% | 1.54% | 16.32% | 17.57% | 9.45% | 14.50% | 24.87% | 13.97% | 8.01% | 22.10% |
| Mar 31, 2016 | 10.34% | 6.82% | 13.60% | 14.44% | 11.10% | 9.84% | 5.75% | 12.74% | 6.80% | 18.33% |
| Mar 31, 2015 | 38.99% | 20.85% | 17.40% | 14.08% | 14.17% | 11.11% | 12.33% | 13.63% | 5.03% | 17.18% |
| Mar 31, 2014 | 4.37% | 10.61% | 19.51% | 12.23% | 11.11% | 10.60% | 11.89% | 12.39% | 15.76% | 17.31% |
| Mar 31, 2013 | 10.95% | 10.23% | 13.97% | 12.10% | 12.04% | 10.05% | 13.21% | 19.16% | 18.57% | 17.50% |
| Mar 31, 2012 | 1.18% | 22.32% | 16.61% | 10.28% | 12.58% | 11.16% | 13.81% | 18.34% | 21.14% | 17.72% |
| Mar 31, 2011 | -11.22% | 19.35% | 15.90% | 9.10% | 12.85% | 11.36% | 17.60% | 18.71% | 19.39% | 18.17% |
| Mar 31, 2010 | -17.62% | 20.66% | 20.24% | 9.09% | 13.08% | 12.12% | 15.88% | 18.74% | 21.18% | 17.94% |
| Mar 31, 2009 | -27.24% | 25.14% | 24.04% | 10.33% | 9.90% | 19.09% | 18.00% | 15.13% | 16.88% | 16.19% |
| Mar 31, 2008 | -43.73% | 27.92% | 8.13% | 9.29% | 13.43% | 11.62% | 14.52% | 16.13% | 19.34% | 14.33% |
| Mar 31, 2007 | -22.84% | 20.28% | 23.48% | 8.42% | 15.08% | 14.55% | 20.69% | 16.26% | 25.53% | 23.20% |
| Mar 31, 2006 | -42.38% | 12.22% | 26.67% | 13.80% | 16.89% | 12.59% | 15.96% | 12.22% | 27.14% | 19.99% |
| Mar 31, 2005 | -4.17% | 23.39% | 30.32% | 14.70% | 17.67% | 9.86% | 12.47% | 21.27% | 17.26% | 18.61% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., ROE, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | 9.08% | 15.23% |
| Mar 31, 2021 | 16.96% | 14.96% |
| Mar 31, 2020 | 19.05% | 14.51% |
| Mar 31, 2019 | 27.65% | 13.87% |
| Mar 31, 2018 | 16.27% | 9.39% |
| Mar 31, 2017 | 11.53% | 13.46% |
| Mar 31, 2016 | 10.34% | 11.29% |
| Mar 31, 2015 | 38.99% | 12.80% |
| Mar 31, 2014 | 4.37% | 13.37% |
| Mar 31, 2013 | 10.95% | 13.46% |
| Mar 31, 2012 | 1.18% | 15.49% |
| Mar 31, 2011 | -11.22% | 14.75% |
| Mar 31, 2010 | -17.62% | 15.16% |
| Mar 31, 2009 | -27.24% | 16.57% |
| Mar 31, 2008 | -43.73% | 14.61% |
| Mar 31, 2007 | -22.84% | 16.83% |
| Mar 31, 2006 | -42.38% | 16.84% |
| Mar 31, 2005 | -4.17% | 16.90% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
Abiomed Inc., ROE, long-term trends, comparison to industry (health care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | 9.08% | 22.36% |
| Mar 31, 2021 | 16.96% | 22.87% |
| Mar 31, 2020 | 19.05% | 16.00% |
| Mar 31, 2019 | 27.65% | 21.03% |
| Mar 31, 2018 | 16.27% | 17.45% |
| Mar 31, 2017 | 11.53% | 14.32% |
| Mar 31, 2016 | 10.34% | 17.89% |
| Mar 31, 2015 | 38.99% | 18.18% |
| Mar 31, 2014 | 4.37% | 18.66% |
| Mar 31, 2013 | 10.95% | 18.20% |
| Mar 31, 2012 | 1.18% | 17.48% |
| Mar 31, 2011 | -11.22% | 15.35% |
| Mar 31, 2010 | -17.62% | 14.63% |
| Mar 31, 2009 | -27.24% | 19.52% |
| Mar 31, 2008 | -43.73% | 18.97% |
| Mar 31, 2007 | -22.84% | 17.18% |
| Mar 31, 2006 | -42.38% | 20.41% |
| Mar 31, 2005 | -4.17% | 18.45% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).